Receptors, Fibroblast Growth Factor, antagonists & inhibitors
DBCAT002854Pharmacologic class
A DrugBank category of 4 drugs. 3 of them are approved.
What you can answer from here — as of October 24, 2016
Which targets do Receptors, Fibroblast Growth Factor, antagonists & inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account